Abstract
(1) Background: The purpose of this study was to determine whether preemptive duloxetine in patients with central sensitization (CS) is effective for acute postoperative pain control and wound healing following total knee arthroplasty (TKA). (2) Methods: CS was defined as a score of 40 points or higher on the Central Sensitization Inventory (CSI) survey. Thirty-nine patients with CS were randomly assigned to either the duloxetine group (n = 19) or the placebo group (n = 20). The duloxetine group took duloxetine 30 mg once a day, while the placebo group took the placebo medication once a day. A pain visual analog scale (VAS) and the Brief Pain Inventory (BPI), wound complications, the temperature of the surgical site, and adverse events were investigated. Skin temperature was measured at the center of the patella using a portable digital thermometer. (3) Results: The duloxetine group reported significantly lower pain VAS scores during follow-up periods up to 6 weeks after surgery (all p < 0.05). BPI interference also showed significantly superior results in the duloxetine group after surgery (all p < 0.05). Although there was no difference in the rate of wound complications between the two groups (p > 0.05), the duloxetine group showed significantly lower wound temperature than the placebo group during the follow-up period (all p < 0.05). (4) Conclusion: In this study, preemptive duloxetine effectively reduced pain and lowered wound temperature following TKA in CS patients.
Highlights
Total knee arthroplasty (TKA) is the most effective treatment for end-stage knee osteoarthritis (OA) [1]
Perioperative pain is closely related to surgical stress response [4]
Patients who met all of the following standards were allowed to participate in this study: (1) surgery performed for primary knee OA; (2) American Society of Anesthesiologists (ASA) class of I, II, or III; (3) completion of the study informed consent form; and (4) more than 3 months of available follow-up data
Summary
Total knee arthroplasty (TKA) is the most effective treatment for end-stage knee osteoarthritis (OA) [1]. It is an established surgical method that reduces pain and provides a better quality of life through functional enhancement. About 20% of patients who undergo TKA are not satisfied with the results of the operation due to persistent pain [2,3]. Perioperative pain is closely related to surgical stress response [4]. Various pain control methods have been used to reduce surgical stress response as well as perioperative pain [5,6]. Despite the remarkable developments in multimodal pain analgesia in recent years, pain control after TKA surgery remains challenging
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
